BIICX | FCANX | BIICX / FCANX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 7.621 | 5.408 | 141% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 0 | - |
Min. Initial Investment IRA | N/A | 500 | - |
Net Assets | 10.8B | 1.99B | 543% |
Annual Yield % from dividends | 5.83 | 1.80 | 325% |
Returns for 1 year | 13.73 | 10.69 | 128% |
Returns for 3 years | 4.73 | -3.46 | -137% |
Returns for 5 years | 21.51 | 10.91 | 197% |
Returns for 10 years | 48.17 | 18.49 | 260% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMHX | 8.00 | -0.03 | -0.37% |
MFS Emerging Markets Equity Research R6 | |||
PSAPX | 28.30 | -0.26 | -0.91% |
Principal SmallCap S&P 600 Index R1 | |||
JSEPX | 47.40 | -0.45 | -0.94% |
JPMorgan Small Cap Equity R3 | |||
BOPAX | 28.83 | -0.49 | -1.67% |
Sterling Capital Special Opps A | |||
HLHIX | 29.15 | -0.68 | -2.28% |
Virtus KAR Health Sciences Inst |